Peter Angus

15.2k total citations · 1 hit paper
248 papers, 9.8k citations indexed

About

Peter Angus is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Peter Angus has authored 248 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Hepatology, 134 papers in Epidemiology and 59 papers in Surgery. Recurrent topics in Peter Angus's work include Liver Disease Diagnosis and Treatment (93 papers), Liver Disease and Transplantation (89 papers) and Hepatitis C virus research (58 papers). Peter Angus is often cited by papers focused on Liver Disease Diagnosis and Treatment (93 papers), Liver Disease and Transplantation (89 papers) and Hepatitis C virus research (58 papers). Peter Angus collaborates with scholars based in Australia, United States and New Zealand. Peter Angus's co-authors include Paul Gow, Chandana B. Herath, Christopher Leung, John B. Furness, Leni R. Rivera, John Lubel, Geoffrey W. McCaughan, Marie Sinclair, Mathis Grossmann and Louise M. Burrell and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Peter Angus

245 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of the gut microbiota in NAFLD

2016 779 citations Peter Angus et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Angus Australia	55	5.9k	5.3k	1.6k	1.2k	1.1k	248	9.8k
Aijaz Ahmed United States	53	7.8k 1.3×	5.5k 1.0×	1.8k 1.2×	948 0.8×	2.1k 1.8×	322	10.7k
George N. Ioannou United States	59	8.0k 1.4×	5.6k 1.1×	2.1k 1.3×	2.0k 1.7×	1.7k 1.5×	211	12.6k
Misael Uribe Mexico	45	4.5k 0.8×	3.2k 0.6×	2.1k 1.3×	960 0.8×	1.3k 1.1×	328	7.8k
Bruce R. Bacon United States	66	12.7k 2.1×	10.4k 2.0×	2.0k 1.3×	1.9k 1.6×	2.2k 1.9×	284	21.7k
Agustı́n Albillos Spain	57	7.7k 1.3×	7.6k 1.4×	4.0k 2.5×	1.7k 1.5×	540 0.5×	269	11.8k
Flemming Bendtsen Denmark	53	8.0k 1.4×	6.5k 1.2×	4.1k 2.6×	1.2k 1.0×	1.3k 1.1×	340	12.1k
Jörn M. Schattenberg Germany	50	6.7k 1.1×	3.4k 0.6×	1.5k 1.0×	1.6k 1.4×	2.5k 2.2×	332	9.2k
Coleman I. Smith United States	21	7.9k 1.3×	6.6k 1.3×	673 0.4×	1.0k 0.9×	1.5k 1.3×	55	9.8k
Nahúm Méndez‐Sánchez Mexico	43	4.2k 0.7×	2.4k 0.5×	2.0k 1.3×	1.1k 1.0×	1.3k 1.1×	302	7.8k
Emmanuel Tsochatzis United Kingdom	55	12.1k 2.0×	9.4k 1.8×	3.4k 2.1×	1.4k 1.2×	2.5k 2.2×	308	15.8k

Countries citing papers authored by Peter Angus

Since Specialization

Citations

This map shows the geographic impact of Peter Angus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Angus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Angus more than expected).

Fields of papers citing papers by Peter Angus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Angus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Angus. The network helps show where Peter Angus may publish in the future.

Co-authorship network of co-authors of Peter Angus

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Angus. A scholar is included among the top collaborators of Peter Angus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Angus. Peter Angus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoermann, Rudolf, Marie Sinclair, Brooke Chapman, et al.. (2024). Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial. Alimentary Pharmacology & Therapeutics. 59(8). 941–952. 10 indexed citations

Chapman, Brooke, Su Kah Goh, Frank Parker, et al.. (2022). Malnutrition and low muscle strength are independent predictors of clinical outcomes and healthcare costs after liver transplant. Clinical Nutrition ESPEN. 48. 210–219. 22 indexed citations

Casey, Stephen, Tawar Qaradakhi, Anthony Zulli, et al.. (2022). Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats. Hepatology Communications. 6(9). 2523–2537. 8 indexed citations

Angus, Peter, et al.. (2021). Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. Journal of Clinical Medicine. 10(4). 702–702. 29 indexed citations

Laybutt, D. Ross, et al.. (2021). Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver. Hepatology Communications. 6(5). 1056–1072. 7 indexed citations

Jeffrey, Gary P., Michael Stormon, Gordon Thomas, et al.. (2020). Outcomes for children after second liver transplantations are similar to those after first transplantations: a binational registry analysis. The Medical Journal of Australia. 213(10). 464–470. 3 indexed citations

Asgari, Samira, Nimisha Chaturvedi, Petar Šćepanović, et al.. (2018). Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients. Journal of Viral Hepatitis. 26(2). 271–277. 4 indexed citations

Cioccari, Luca, E Osawa, Kelly Jones, et al.. (2018). Outcome of Acetaminophen‐Induced Acute Liver Failure Managed Without Intracranial Pressure Monitoring or Transplantation. Liver Transplantation. 25(1). 35–44. 14 indexed citations

Bertot, Luis Calzadilla, Gary P. Jeffrey, Luc Delrivière, et al.. (2017). Non-alcoholic steatohepatitis is an important growing indication for liver transplantation in Australia and New Zealand. Hepatology. 66. 1 indexed citations

10.

Zeuzem, Stefan, Parvez Mantry, Vincent Soriano, et al.. (2016). Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. European Journal of Gastroenterology & Hepatology. 28(8). 923–926. 1 indexed citations

11.

Zeuzem, Stefan, Vincent Soriano, Tarik Asselah, et al.. (2014). Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis. Antimicrobial Agents and Chemotherapy. 59(2). 1282–1291. 8 indexed citations

12.

Sinclair, Marie, et al.. (2014). Low-Serum Testosterone Levels Pre-Liver Transplantation Are Associated With Reduced Rates of Early Acute Allograft Rejection in Men. Transplantation. 98(7). 788–792. 3 indexed citations

13.

Zeuzem, Stefan, Tarik Asselah, Peter Angus, et al.. (2013). Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results. Antiviral Therapy. 18(8). 1015–1019. 33 indexed citations

14.

Lim, Lucy, Scott J. Patterson, Jacob George, et al.. (2012). Tenofovir Rescue Therapy Achieves Long-Term Suppression of HBV Replication in Patients with Multi-Drug Resistant HBV: 4 Year Follow-Up of the TDF109 Cohort. Hepatology. 56. 3 indexed citations

15.

Angus, Peter & Scott J. Patterson. (2008). Liver transplantation for hepatitis B: What is the best hepatitis B immune globulin/antiviral regimen?. Liver Transplantation. 14(S2). S15–S22. 26 indexed citations

16.

Hong, Matthew, Peter Angus, Robert M. Jones, Rhys Vaughan, & Paul Gow. (2005). Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post‐liver transplant renal dysfunction. Clinical Transplantation. 19(2). 193–198. 11 indexed citations

17.

Crawford, Dorothy H., Linda Fletcher, Stefan G. Hübscher, et al.. (2004). Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis. Hepatology. 39(6). 1655–1662. 55 indexed citations

18.

Angus, Peter, Hany Ghabrial, S. T. Chou, et al.. (1995). Right heart failure impairs hepatic oxygenation and theophylline clearance in rats.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1332–1336. 11 indexed citations

19.

Jones, Robert M., et al.. (1993). Beneficial effect of prostaglandin E1 on hepatic allograft rejection following orthotopic liver transplantation.. PubMed. 25(5). 2890–1. 14 indexed citations

20.

Dixon, Ruth, Peter Angus, B. Rajagopalan, & George K. Radda. (1992). 31P Magnetic Resonance Spectroscopy Detects A Functional Abnormality in Liver Metabolism After Acetaminophen Poisoning. Hepatology. 16(4). 943–948. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact